USFDA ESG NextGen Update: FAERS Submission Type Removal
USFDA ESG NextGen Update: The U.S. Food and Drug Administration (FDA) is developing its regulatory submission systems under the Electronic Submission Gateway NextGen (ESG NextGen) system. There was a significant change that has been made regarding the FDA Adverse Event Reporting System (FAERS) recently. Some forms of submissions to FAERS have been eliminated and cease to be effective without delay.
Understanding Regulatory Affairs in Life Sciences
Regulatory affairs play a critical role in ensuring that biotechnology and pharmaceutical products are safe, effective, and compliant with global health authority requirements. From early research to post-market surveillance, regulatory professionals act as a bridge between scientific innovation and regulatory compliance, enabling products to reach patients responsibly and efficiently.
What Are GMP Practices?
Good Manufacturing Practices (GMP) are guidelines and regulations, which manufacturers are supposed to adhere to assure that products are manufactured and under controlled conditions, which are hygienic and reliable. Regulatory authorities including the U.S FDA, EMA in Europe and the WHO enforce these practices in order to protect the health of the people.
FDA 21 CFR Part 11 Compliance Checklist: A Practical Guide
Regulation 21 CFR Part 11 FDA lays down the requirements according to which the electronic records and electronic signatures should be regarded as credible, dependable, and identical to the paper records and handwritten signatures. Part 11 compliance is mandatory in those life sciences organizations that employ electronic systems in the GMP, GLP, and GCP controlled settings.
Healthcare Compliance Program: Regulatory Compliance Framework
A structured system created to guarantee that healthcare organizations follow relevant laws, rules, and ethical standards is known as a healthcare compliance program. A key element of these programs is regulatory compliance, which aids organizations in lowering legal risks, safeguarding patient safety, and preserving confidence with stakeholders, patients, and regulators.